Multiple biomarkers for the prediction of first major cardiovascular events and death: Considerable costs and limited benefits

MedGenMed Medscape General Medicine

Volumn 9, Issue 1, 2007, Pages

  Lippi, Giuseppe ^a   Salvagno, Gian Luca ^a   Targher, Giovanni ^a   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE; D DIMER; FIBRINOGEN; HOMOCYSTEINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RENIN;

ACCURACY; CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; DISEASE COURSE; DISEASE MARKER; GENE TARGETING; HEALTH CARE COST; HUMAN; LETTER; MORBIDITY; MORTALITY; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; URINALYSIS; CAUSE OF DEATH; ECONOMICS; PREDICTION AND FORECASTING;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; HUMANS; PREDICTIVE VALUE OF TESTS;

EID: 33847302445     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM. 2006;8:27-31. Abstract
2. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631-2639. Abstract
3. US Census Bureau. Statistical Abstract of the United States: 2006. Available at: http://www.census.gov/prod/2005pubs/06statab/pop.pdf Accessed January 19, 2007.
4. National Heart Lung and Blood Institute. Disease statistics. Available at: http://www.nhlbi.nih.gov/about/factbook/chapter4.htm Accessed January 19, 2007.